EICHOR
● Completed
Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer · Sponsor: Eastern Cooperative Oncology Group
About this study
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Monoclonal antibodies can locate cancer cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether cisplatin plus monoclonal antibody therapy is more effective than cisplatin alone for metastatic or recurrent head and neck cancer. PURPOSE: Randomized double-blinded phase III trial to compare the effectiveness of cisplatin with or without monoclonal antibody in treating patients who have metastatic or recurrent head and neck cancer.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (76)
| CCOP - Scottsdale Oncology Program | Scottsdale, Arizona, United States | — |
| Mayo Clinic Scottsdale | Scottsdale, Arizona, United States | — |
| Beckman Research Institute, City of Hope | Los Angeles, California, United States | — |
| Veterans Affairs Medical Center - Palo Alto | Palo Alto, California, United States | — |
| Stanford University Medical Center | Stanford, California, United States | — |
| CCOP - Colorado Cancer Research Program, Inc. | Denver, Colorado, United States | — |
| Yale Comprehensive Cancer Center | New Haven, Connecticut, United States | — |
| CCOP - Christiana Care Health Services | Wilmington, Delaware, United States | — |
| Walter Reed Army Medical Center | Washington D.C., District of Columbia, United States | — |
| Veterans Affairs Medical Center - Gainsville | Gainesville, Florida, United States | — |
| Sylvester Cancer Center, University of Miami | Miami, Florida, United States | — |
| H. Lee Moffitt Cancer Center and Research Institute | Tampa, Florida, United States | — |
+ 64 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00003809